|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
4/11/16 Intellia Therapeutics, Inc. CORRESP¶ 6/3/16 1:11K Donnelley … Solutions/FA
4/11/16 Intellia Therapeutics, Inc. S-1 17:8.5M Donnelley … Solutions/FA
3/17/16 Intellia Therapeutics, Inc. DRS/A¶ 4/11/16 5:5.3M Donnelley … Solutions/FA
12/22/15‡ Intellia Therapeutics, Inc. DRS/A¶ 4/11/16 4:2.2M Donnelley … Solutions/FA
10/14/15‡ Intellia Therapeutics, Inc. DRS/A¶ 4/11/16 2:2.2M Donnelley … Solutions/FA
9/4/15 Intellia Therapeutics, Inc. DRS¶ 4/11/16 9:4.7M ActiveDisclosure/FA
____________ | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | ¹ | Filing/Form Types: | | CORRESP | Comment-Response or Other Letter to the SEC. | | DRS | Draft Registration Statement by an Emerging Growth Company or Foreign Issuer — Form DRS. | | S-1 | Registration Statement (General Form) — Form S-1. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | | ¶ | This Filing contains a delayed-release Document. |
|